 |
|
Outcome After Surgical Repair of Junctional Epidermolysis Bullosa–Pyloric Atresia Syndrome
A Report of 3 Cases and Review of the Literature
Jan P. Dank, MD;
Susan Kim, MD;
Melissa A. Parisi, MD, PhD;
Tod Brown, PhD;
Lynne T. Smith, PhD;
John Waldhausen, MD;
Virginia P. Sybert, MD
Arch Dermatol. 1999;135:1243-1247.
ABSTRACT
| |
Background Junctional epidermolysis bullosa–pyloric atresia syndrome is recognized as a distinct autosomal recessive entity. Affected infants present with skin fragility and inability to feed due to intestinal obstruction. Despite successful surgical repair of the anatomical defect, the outcome is poor owing to poor feeding, malabsorption, failure to thrive, and sepsis.
Observations In 70 cases of intestinal obstruction and epidermolysis bullosa reported in the medical literature and the 3 reported here, surgical intervention was attempted 51 times. In all except 16 infants, death occurred before age 11 months (mean age, 70 days). Renal involvement and continued failure to thrive accompanied the skin disease in survivors, who ranged in age from 30 days to 16 years (mean age, 4.0 years).
Conclusions The poor prognosis of this condition must be considered when decisions are made regarding surgical correction. Attempting surgical correction may be warranted in individual circumstances, but withholding surgical intervention and providing palliative support is an acceptable alternative.
INTRODUCTION
JUNCTIONAL epidermolysis bullosa–pyloric atresia syndrome (JEB-PA) is a rare, autosomal recessive disorder characterized by the association of congenital atresia of the gastric antrum or pylorus with bullous disease of the skin and oral mucosa.1 This condition was considered part of the category of JEB gravis, but it has recently been recognized as a distinct genetic subset with molecular defects distinct from those found in JEB gravis.2-6
In JEB-PA, the PA and resultant gastrointestinal tract obstruction demand a decision regarding surgical correction. Most infants who undergo surgical correction die within the first months of infancy from a variety of other causes, among which gastrointestinal and nutrition-related problems are particularly important.1, 7-13 We report our experience with 3 patients with JEB-PA. Despite successful surgical intervention in 2 of the cases, failure to thrive and death ensued. In the third case, an infant with both JEB-PA and aplasia cutis congenita, surgical correction was not attempted after consultation with the parents.
REPORT OF CASES
CASE 1
A male infant was born at 37 weeks' gestation to a gravida 8, para 3-4 mother with 2 previous therapeutic and 2 spontaneous abortions. Three older maternal half siblings were healthy without history of bullous skin disease or bowel obstruction. The infant in this case was the product of the first pregnancy for this couple. Prenatal history was notable for polyhydramnios. After birth, excessive spitting and desaturation were noted during feeding. Radiographs revealed a large stomach with a "single bubble" sign and no gas visible in the small bowel, consistent with the presence of PA. Coincidentally, there was progressive blister formation at sites of minor trauma on the extremities, back, and face and in the oropharynx.
Light microscopy findings of skin biopsy specimens showed pauci-inflammatory subbasal vesicle formation. Transmission electron microscopy (EM) demonstrated a split above the level of the basal lamina with hemidesmosomes reduced in number and many without subbasal dense plates or substantial attachment plaques, confirming a diagnosis of JEB. Immunoperoxidase staining showed normal linear staining along the dermoepidermal junction with antibodies to laminin 5, type VII collagen, type IV collagen, and bullous pemphigoid antigen ( 6: GoH3, BQ16;  4: 3E1, 3D5, UM-A9, 450-11a, 439-9b).14 (3D5 is an antibody recognizing an intracellular epitope of integrin 4 subunit.) Staining for integrin 64 was greatly reduced, and the 4 subunit exhibited an enhanced detergent sensitivity indicative of a faulty structural organization.15
At age 12 days, the patient underwent successful surgical repair of the PA. Operative findings included an annular pancreas. A thick fibrotic band of muscularis and submucosal tissue without any visible lumen connected the stomach and the small intestine at the site where the pylorus would have been expected. The surgical wound healed normally without any blistering. Feeding problems persisted, and the patient had trouble with secretions. Videofluoroscopic examination results showed swallowing dysmotility that necessitated continuation of nasoduodenal feeding. Despite maintenance on hyperalimentation and regular supplementation with breast milk, he failed to gain weight adequately. Admission weight was 2.34 kg; weight at discharge at age 55 days was 2.57 kg. A fecal 1-antitrypsin level was lower than 0.3 mg/g (normal, 0.1-3.0 mg/g). Blisters continued to form at sites of minor trauma, but these rapidly healed, and the extent of skin involvement was relatively minor and manageable. He had one urinary tract infection with Escherichia coli. He was discharged to home with nasogastric hyperalimentation supplemented with breast milk; he was scheduled for weekly physician office visits and close home nursing follow-up. He died at home at age 12 weeks of presumed sepsis and severe failure to thrive. No postmortem examination was performed.
CASE 2
A premature male infant was born at 29 5/7 weeks' gestation to a gravida 1 mother. The pregnancy was uncomplicated until premature labor and early cesarean delivery owing to breech presentation. After Apgar scores of 4 at 1 minute and 7 at 5 minutes, he developed severe respiratory distress requiring intubation. Shortly after birth, he had several areas of skin disruption and sloughing, particularly of the hands, feet, face, and areas suffering minor local trauma. Electron microscopy findings of a skin biopsy specimen confirmed a diagnosis of JEB showing the split to be at the lamina lucida level. Immunoperoxidase analysis findings demonstrated decreased staining for integrin 64 and a greater reduction in the 4 subunit level (6: GoH3; 4: 3E1, 3D5, 439-9b). Radiologic contrast study results of the gastrointestinal tract revealed obstruction at the level of the pylorus.
At age 9 days, successful surgical repair of the PA was performed. Eight days later, tube feeds were begun but not tolerated at full strength or rate owing to large gastric residuals and emesis. Despite additional efforts, he was unable to tolerate gastrointestinal feeding, and parenteral nutrition was required. Extubation was achieved at age 24 days, but declining respiratory status required reintubation at age 28 days. After extensive family conferences, a decision was made to withdraw support. At age 31 days, the patient died within a few hours of extubation. Postmortem examination was refused.
CASE 3
A female infant was born at 30 5/7 weeks' gestation to a 27-year-old gravida 3, para 0-1 mother. She had had 2 previous intrauterine fetal demises in Mexico. The father of all 3 pregnancies was from the same small town in southern Mexico, but there was no known consanguinity or any family members with blistering skin disease or perinatal deaths. The prenatal history included "small femurs" per results of a second-trimester ultrasound performed in the United States. As a result of fetal distress and premature labor, cesarean delivery was done; the infant weighed 1.42 kg and had several areas of absent skin on her scalp and extremities, including the right lower extremity from the inguinal region to the foot, with concomitant symmetric undergrowth of that leg relative to the left. Radiographs revealed a prominent single stomach bubble and absence of bowel gas distal to the stomach. Enteral feeding was not attempted, and an orogastric tube was placed for decompression. Surgical consultation was obtained for the probable PA. Transmission EM examination of skin biopsy specimens showed a split at the lamina lucida, and immunohistochemical staining showed absence of staining for integrin 4 (UM-A9; 3D5) and reduced integrin 6 expression (GoH3; BQ16).
After discussion with the mother, hyperalimentation and aggressive fluid administration were discontinued. With continued medical treatment directed at her comfort, the infant died on the fifth day of life.
COMMENT
Epidermolysis bullosa (EB) encompasses a group of disorders that manifest as fragility of the skin leading to blister formation after minor mechanical trauma. The disorders are heterogeneous, with distinct clinical courses and patterns of inheritance.16 The primary distinction among the different conditions that make up EB is the level within the skin at which blister formation occurs. In JEB, the separation is within the lamina lucida of the basement membrane.
Junctional EB has at least 3 distinct subtypes: JEB generalized atrophic benign, JEB gravis, and JEB-PA, all of which show autosomal recessive inheritance and usually present at or shortly after birth. Junctional EB generalized atrophic benign, also called JEB-mitis or generalized atrophic benign EB, has a more benign clinical course than the other subtypes and is characterized by fragile skin and blistering in a generalized distribution. Affected individuals have dystrophic nails, oral lesions, esophageal and urinary tract involvement, and scarring alopecia. Obstructive urinary tract abnormalities and their complications, in addition to the fragile skin, pose the primary problems of long-term management, but early lethality is rare. Defects in either laminin 5 or the 180-kd bullous pemphigoid antigen, both components of the hemidesmosome complex, have been described in JEB generalized atrophic benign.17 Junctional EB gravis (also known as letalis or Herlitz variant) is a more severe disease that is most often lethal in infancy. There is widespread generalized blistering, mucosal involvement, and often problems with fluid and electrolytes, as well as sepsis. Exuberant granulation tissue that can form vegetating lesions and severe growth retardation are common in longer-term survivors. Involvement of the respiratory and urinary tracts is also clinically significant. In patients with JEB gravis who survive infancy, life expectancy is substantially shortened. In JEB gravis, mutations have also been identified in components of laminin 5.18
A subset of patients with JEB also have PA. These infants were initially classified with infants having JEB gravis because of the severity of the disease and the outcome. Based on concordance among affected siblings for both PA and JEB, it was hypothesized that JEB-PA was a distinct syndrome and not the result of a chance association.1 Uncertainty still existed as to whether the PA was an independent manifestation of the same gene or if it occurred as a secondary phenomenon of repeated blistering of the pyloric mucosa. One infant in whom pyloric obstruction seemed to develop at age 1 month provided support for the latter idea.19 That PA had never been reported in EM-confirmed simplex or dystrophic forms of EB that also have gastrointestinal tract involvement argued against it.4, 20 Recently mutations in integrin 64, and not the laminin 5 mutations found in JEB gravis, have been identified in cases where JEB is associated with PA, confirming that JEB-PA is a genetically distinct entity.2-3,6, 15, 21-26 Further, integrin 64 is responsible for the skin and pyloric abnormalities in integrin 4 null mice.27-28
Integrin 64 is a heterodimer transmembrane component of the hemidesmosome complex. It is a receptor for the extracellular ligand laminin 5. Together, these hemidesmosomal components allow basal keratinocytes to form stable cell adhesions to the epidermal basement membrane. This explains the shared ultrastructural features of JEB gravis and JEB-PA and the distinct immunofluorescent findings.29-32
We found 70 cases of newborn infants with PA and EB in the literature, plus the 3 cases reported here.1-13,15, 19-26,33-55 The standard for the diagnosis of JEB-PA is transmission EM evidence of blister formation in the skin at the level of the lamina lucida and alterations in hemidesmosome structure, in conjunction with PA. Nonetheless, we included those cases of EB in which PA was seen, even if no EM confirmation was available. In 22 cases, EM studies were not performed (n=18), were uninterpretable (n=2), or were suggestive of other types of EB (n=2). These last 2 cases deserve mention regarding the diagnosis of dystrophic vs junctional disease. In one, while PA was present, EM findings were interpreted as consistent with dystrophic, not junctional, EB.45 The authors classified EB into dystrophic and simplex without recognition of a junctional variant. No electron micrographs were provided. The description of findings was "discontinuity of the basement membrane."45 This is consistent with the EM features of JEB-PA. In the second report (case B), there were no details given of the EM findings.51 The authors stated that the EM diagnosis of dystrophic disease was at odds with the lack of clinically evident scarring. Thus the evidence supporting an association of PA with forms of EB other than junctional is not convincing.
Two infants with JEB did not have gastrointestinal atresia.3, 42 Their siblings (n=2 and n=1, respectively) did.
In addition to PA, other commonly reported complications in these patients included premature birth (n=37), polyhydramnios (n=37), aplasia cutis congenita or congenital localized absence of skin (n=17) (confirming that this feature is not limited to dystrophic EB); and urinary tract involvement (6 of the survivors, 13 of those who died).
In 51 cases, surgical repair of the PA was attempted (Table 1). 1-5,7-13,15, 19-21,23-25,33-37,45, 47, 50-52,54-55 Despite successful repair, the outcome was nevertheless fatal in 35 of the 51. The mean age of death in this group was 70 days. In the 16 survivors, ages ranged from 30 days to 16 years (mean age, 4.0 years; median age, 2.75 years). One of the long-term survivors reported at age 22 months had acquired rather than congenital PA.19 Three other survivors did not develop blisters until after age 1 week, 3 months, and 2 years, respectively.15
|
|
|
|
Outcome of Infants With Junctional Epidermolysis Bullosa–Pyloric Atresia Syndrome After Surgical Repair of Gastrointestinal Tract Obstruction*
|
|
|
Many infants die of this disorder owing to the extensive denudation of skin, resultant loss of barrier function, fluid and electrolyte problems, and sepsis. A minority tolerate the surgical correction of the gastrointestinal tract obstruction and seem to have a limited and manageable extent of skin and mucous membrane blistering. Our 3 patients are in many ways typical. The first 2, despite surgical correction of the anatomical defect and manageable, limited blistering, had fatal outcomes. Difficulty with oral feedings and the development of diarrhea with a protein-losing enteropathy seem to be common features in many of these infants, including survivors, and are major contributing factors to death in early infancy. The urinary and respiratory tract difficulties experienced by infants with JEB-PA can in part be explained by the fact that the epithelium of the upper airway and the transitional epithelium of the bladder and urinary tract, in common with the skin, have basement membranes in which hemidesmosomes are found. The cause of the PA and malabsorption is not intuitively obvious, as hemidesmosomes per se are not found in gut epithelium. However, some of the proteins that make up hemidesmosomes, including integrin 64, are found in the basement membrane zone of normal human gut epithelium.56 The occurrence of gastrointestinal tract involvement in mice with JEB-PA in which the cytoplasmic domain of integrin 4 subunit has been deleted27 suggests that integrin 64 serves both structural and signal transduction roles in the human intestine.
Survivability in JEB-PA may be limited to specific mutations (ie, certain alleles may confer lesser likelihood of lethality), as suggested by the concordance of survival among affected siblings and cousins and by preliminary work suggesting that infants homozygous for mutations that result in premature codon termination may have more severe disease.2-3,7, 15, 21-26,39 The number of patients evaluated by molecular studies thus far is small, and no definitive conclusions can be drawn. There may prove to be reliable genotype-phenotype correlations that can allow for more accurate predictions of outcome based on molecular diagnosis, but these are not available now. Similarly, results of immunofluorescence staining for antibodies against 6 and 4 are not predictive of clinical outcome, at least in the few infants studied to date.
When the family and medical team begin to weigh the issues involved in attempting to repair the gastrointestinal tract obstructions found in infants born with JEB-PA, the overall poor prognosis even in the face of successful repair must be considered. Some will view a 25% to 30% chance of survival, even in compromised health, as a chance worth taking. For these families, aggressive support may be the correct choice. Others may believe that such a choice serves only to prolong pain and suffering. For these, a decision to not intervene, but instead to provide palliative care and support, may be appropriate. Uncertainty in individual situations will always make these decisions complicated and difficult.
AUTHOR INFORMATION
Accepted for publication May 14, 1999.
This work was supported in part by training grants 5T32 AR07019 (Drs Dank and Kim) and 5T326M07454 (Dr Parisi) and grant NIH PO1 AR21557-20 (Drs Sybert, Smith, and Brown) from the National Institutes of Health, Bethesda, Md.
Corresponding author: Virginia P. Sybert, MD, Division of Dermatology, Box 356524, University of Washington Medical Center, Seattle, WA 98195-6524 (e-mail: flk01{at}u.washington.edu).
From the Divisions of Dermatology (Drs Dank, Kim, Smith, and Sybert) and Medical Genetics (Dr Parisi), Department of Medicine, University of Washington School of Medicine, the Division of Basic Sciences, Fred Hutchinson Cancer Research Center (Dr Brown), and the Department of Surgery, Children's Hospital and Regional Medical Center (Dr Waldhausen), Seattle, Wash.
REFERENCES
| |
1. Bull MJ, Norins AL, Weaver DD, Weber T, Mitchell M. Epidermolysis bullosa–pyloric atresia, an autosomal recessive syndrome. AJDC. 1983;137:449-451.
2. Vidal F, Aberdam D, Miquel C, et al. Integrin 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet. 1995;10:228-233.
FULL TEXT
3. Pulkkinen L, Kimonis VE, Xu Y, Spanou E, McLean WHI, Uitto J. Homozygous 6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet. 1997;6:669-674.
FREE FULL TEXT
4. Valari MD, Phillips RJ, Lake BD, Harper JI. Junctional epidermolysis bullosa and pyloric atresia, a distinct entity: clinical and pathological studies in five patients. Br J Dermatol. 1995;133:732-736.
ISI
| PUBMED
5. Lacour JP, Hoffman P, Bastiani-Griffet F, Boutte P, Pisani A, Ortonne JP. Lethal junctional epidermolysis bullosa with normal expression of BM 600 and antropyloric atresia: a new variant of junctional epidermolysis bullosa? Eur J Pediatr. 1992;151:252-257.
FULL TEXT
|
ISI
| PUBMED
6. Ruzzi L, Gagnoux-Palzcios L, Pinola M, et al. A homozygous mutation in the integrin 6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest. 1997;99:2826-2831.
ISI
| PUBMED
7. Lund AM, Karlsmark T, Kobayasi T. Protein-losing enteropathy in a child with junctional epidermolysis bullosa and pyloric atresia. Acta Derm Venereol (Stockh). 1995;75:59-61.
ISI
| PUBMED
8. Ishigami T, Akaishi K, Nishimura S, Yokoo T. A case of pyloric atresia associated with junctional epidermolysis bullosa. Eur J Pediatr. 1990;149:306-307.
FULL TEXT
|
ISI
| PUBMED
9. De Groot WG, Postuma R, Hunter AGW. Familial pyloric atresia associated with epidermolysis bullosa. J Pediatr. 1978;92:429-430.
FULL TEXT
|
ISI
| PUBMED
10. Ng CC, Hung FC, Hsieh CS, et al. Epidermolysis bullosa letalis with pyloric atresia in an infant. J Formos Med Assoc. 1996;95:61-65.
ISI
| PUBMED
11. Egan N, Ward R, Olmstead PM, Marks JG. Junctional epidermolysis bullosa and pyloric atresia in two siblings. Arch Dermatol. 1985;121:1186-1188.
ABSTRACT
12. Rosenbloom MS, Ratner M. Congenital pyloric atresia and epidermolysis bullosa letalis in premature siblings. J Pediatr Surg. 1987;22:374-376.
FULL TEXT
|
ISI
| PUBMED
13. El Shafie M, Stidham GL, Klippel CH, Katzman GH, Weinfeld IJ. Pyloric atresia and epidermolysis bullosa letalis: a lethal combination in two premature siblings. J Pediatr Surg. 1979;14:446-449.
ISI
| PUBMED
14. Brown TA, Gil SG, Sybert VP, et al. Defective integrin alpha 6 beta 4 expression in the skin of patients with junctional epidermolysis bullosa and pyloric atresia. J Invest Dermatol. 1996;384-391.
15. Pulkkinen L, Rouan F, Bruckner-Tuderman L, et al. Novel ITG4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense. Am J Hum Genet. 1998;63:1376-1387.
FULL TEXT
|
ISI
| PUBMED
16. Fine JD, Bauer EA, Briggaman RA, et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa: a consensus report by the subcommittee on diagnosis and classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol. 1991;24:119-135.
ISI
| PUBMED
17. Jonkman MF, De Jong MCJM, Heeres K, et al. Generalized atrophic benign epidermolysis bullosa, either 180-kd bullous pemphigus antigen or laminin-5 deficiency. Arch Dermatol. 1996;132:145-150.
ABSTRACT
18. Uitto J, Pulkkinen L, Christiano AM. Molecular basis of the dystrophic and junctional forms of epidermolysis bullosa: mutations in the type VII collagen and kalinin (laminin 5) genes. J Invest Dermatol. 1994;103(suppl):39s-46s.
19. Honig PJ, Yoder M, Ziegler M. Acquired pyloric obstruction in a patient with epidermolysis bullosa letalis. J Pediatr. 1983;102:598-600.
FULL TEXT
|
ISI
| PUBMED
20. Lestringant GG, Akel SR, Qayed KI. The pyloric atresia–junctional epidermolysis bullosa syndrome. Arch Dermatol. 1992;128:1083-1086.
ABSTRACT
21. Pulkkinen L, Kurtz K, Xu Y, Bruckner-Tuderman L, Uitto J. Genomic organization of the integrin 4 gene (ITGB4): a homozygous splice-site mutation in a patient with junctional epidermolysis bullosa associated with pyloric atresia. Lab Invest. 1997;76:823-833.
ISI
| PUBMED
22. Ruzzi L, Gagnoux-Padacios L, Pinola M, et al. A homozygous mutation in the integrin 6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest. 1997;99:2826-2831.
23. Pulkkinen L, Bruckner-Tuderman L, August C, Uitto J. Compound heterozygosity for missense (L156P) and nonsense (R554X) mutations in the 4 integrin gene (ITGB4) underlies mild, nonlethal phenotype of epidermolysis bullosa with pyloric atresia. Am J Pathol. 1994;152:935-941.
24. Pulkkinen L, Kim DU, Uitto J. Epidermolysis bullosa with pyloric atresia: novel mutations in the 4 integrin gene (ITGB4). Am J Pathol. 1994;152:157-166.
25. Mellerio JE, Pulkkinen L, McMillan JR, et al. Pyloric atresia junctional epidermolysis bullosa syndrome: mutations in the integrin 4 gene (ITGB4) in two unrelated patients with mild disease. Br J Dermatol. 1998;139:862-871.
FULL TEXT
|
ISI
| PUBMED
26. Takizawa Y, Shimizu H, Nishikawa T, Hatta N, Pulkkinen L, Uitto J. Novel ITGB4 mutations in a patient with junctional epidermolysis bullosa-pyloric atresia syndrome and altered basement membrane zone immunofluorescence for the 64 integrin. J Invest Dermatol. 1997;108:943-946.
FULL TEXT
|
ISI
| PUBMED
27. Murgia C, Blaikie P, Kim N, Dans M, Petrie HT, Giancotti FG. Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin 4 cytoplasmic domain. EMBO J. 1998;17:3940-3951.
FULL TEXT
|
ISI
| PUBMED
28. Dowling J, Yu QC, Fuchs E. 4 integrin is required for hemidesmosomal formation, cell adhesion and cell survival. J Cell Biol. 1996;134:559-572.
FREE FULL TEXT
29. Eady RAJ, McGrath JA, McMillan JR. Ultrastructural clues to genetic disorders of skin: the dermal-epidermal junction. J Invest Dermatol. 1994;103(suppl):13s-18s.
30. Jonkman MF, de Jong MCJM, Heeres K, Sonnenberg A. Expression of integrin 64 in junctional epidermolysis bullosa. J Invest Dermatol. 1992; 99:489-496.
31. Gil SG, Brown TA, Ryan MC, Carter WG. Junctional epidermolysis bullosa: defects in expression of epligrin/nicein/kalinin and integrin b4 that inhibit hemidesmosome formation. J Invest Dermatol. 1994;103(suppl):31s-38s.
32. Shimizu H, Suzumori K, Hatta N, Nishikawa T. Absence of detectable 6 integrin in pyloric atresia-junctional epidermolysis bullosa syndrome. Arch Dermatol. 1996;132: 919-925.
33. Hayashi AH, Galliani CA, Gillis DA. Congenital pyloric atresia and junctional epidermolysis bullosa: a report of long-term survival and a review of the literature. J Pediatr Surg. 1991;26:1341-1345.
FULL TEXT
|
ISI
| PUBMED
34. Berger TG, Detlefs RL, Donatucci CF. Junctional epidermolysis bullosa, pyloric atresia, and genitourinary disease. Pediatr Dermatol. 1996;3:130-134.
35. Orense M, Garcia Hernandez JB, Celorio C, Canga C. Pyloric atresia associated with epidermolysis bullosa. Pediatr Radiol. 1987;17:435.
FULL TEXT
|
ISI
| PUBMED
36. Nazzaro V, Nicolini U, De Luca L, Berti E, Caputo R. Prenatal diagnosis of junctional epidermolysis bullosa associated with pyloric atresia. J Med Genet. 1990;27:244-248.
ABSTRACT
37. Rosenberg D, Dodat H, Cottin X, Cambazard F, Chappuis JP, Salle B. Atteinte du tractus urinaire au cours du syndrome épidermolyse bulleuse congénitale-atrésie de pylore. Arch Fr Pediatr. 1987;44:867-870.
ISI
| PUBMED
38. Adashi EY, Louis FJ, Vasquez M. An unusual case of epidermolysis bullosa hereditaria letalis with cutaneous scarring and pyloric atresia. J Pediatr. 1980;96:443-446.
FULL TEXT
|
ISI
| PUBMED
39. Shimuzu H, Fine JD, Suzumori K, Hatta N, Shozu M, Nishikawa T. Prenatal exclusion of pyloric atresia-junctional epidermolysis bullosa syndrome. J Am Acad Dermatol. 1994;31:429-433.
ISI
| PUBMED
40. Dennery PA, Conover PT, Kahn T, Jacobs G, Walsh-Sukys C. Premature twins with skin lesions and gastric outlet obstruction. J Pediatr. 1992;120:645-651.
FULL TEXT
|
ISI
| PUBMED
41. Weber M. Hemidesmosome deficiency of gastro-intestinal mucosa, demonstrated in a child with Herlitz syndrome and pyloric atresia. Acta Derm Venereol (Stockh). 1987;67:360-362.
ISI
| PUBMED
42. Vivona G, Frontali M, Di Nunzio ML, Vendemiati A. Aplasia cutis congenita and/or epidermolysis bullosa [letter]. Am J Med Genet. 1987;26:497-502.
FULL TEXT
|
ISI
| PUBMED
43. Peltier FA, Tschen EH, Raimer SS, Kuo TT. Epidermolysis bullosa letalis associated with congenital pyloric atresia. Arch Dermatol. 1981;117:728-731.
ABSTRACT
44. Nesin M, Seymour C, Kim Y. Role of elevated alpha-fetoprotein in prenatal diagnosis of junctional epidermolysis bullosa and pyloric atresia. Am J Perinatol. 1994;11:286-287.
ISI
| PUBMED
45. Defawe G, Le Mared B, Chevrant-Breton J, Allouis M, Sénécal J. Atrésie du pylore et épidermolyse bulleuse, a propos d'un nouveau cas. Arch Fr Pediatr. 1981;38:511-512.
ISI
| PUBMED
46. Nair PM, Chellam VG, Sabarinathan K. Epidermolysis bullosa: pyloric atresia syndrome. Indian J Pediatr. 1989;56:283-299.
PUBMED
47. Zirn JR, Scott RA, Aronian III JM, Lin AN. Gastric outlet obstruction and gastric infarct in junctional epidermolysis bullosa. Pediatr Dermatol. 1995:12:174-177.
48. Swinburne LM, Kohler HG. Familial pyloric atresia associated with epidermolysis bullosa [letter]. J Pediatr. 1979;94:162.
49. Swinburne LM, Kohler HG. Symmetrical congenital skin defects in siblings [abstract]. Arch Dis Child. 1968;43:499.
50. Pedersen PV, Hertel J. Pyloric atresia and epidermolysis bullosa [letter]. J Pediatr. 1977;91:852-853.
51. Korber JS, Glasson MJ. Pyloric atresia associated with epidermolysis bullosa. J Pediatr. 1977;90:600-601.
FULL TEXT
|
ISI
| PUBMED
52. Müller H, Bode H, Krone C, Anton-Lamprecht I, Orlowska M. Herlitz syndrome and "pyloric atresia." Helv Paediat Acta. 1988;43:457-466.
53. Chang C-H, Perrin EV, Bove KE. Pyloric atresia associated with epidermolysis bullosa: special reference to pathogenesis. Pediatr Pathol. 1983;1:449-457.
PUBMED
54. García-Vallés M, Martinez Caro A, Hernandez Orgaz A. Atresia del píloro y epidermólisis ampollosa Una coincidencia? An Esp Pediatr. 1971;10:745-750.
55. Roman Ortiz ME, Guitierrez Sanchez JD, Rodriguez Caamãno J, et al. Síndrome de atresia pilórica-epidermolisis bullosa congénita: descripción de un nuevo caso. An Esp Pediatr. 1991;35:419-421.
PUBMED
56. Green KJ, Jones JC. Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J. 1996;10:871-881.
ABSTRACT
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 1999;135(10):1282-1283.
FULL TEXT
|
